{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-014047","form_type":"8-K","ticker":"RDGL","cik":"0001449349","company_name":"VIVOS INC","filed_at":"2025-09-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.014485+00:00","generated_at":"2026-05-17T06:14:06.442359+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Vivos Inc. creates wholly owned India subsidiary for manufacturing and therapies","bullets":["Board approved creation of Vivos Scientific India LLP on September 17, 2025.","Entity is wholly owned, aims to establish manufacturing center in India.","Objective includes expanding human therapies and commercialization in India.","Will generate additional human trial data to support FDA approval process."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-014047","json":"https://secwatch.observer/filing/0001493152-25-014047.json","markdown":"https://secwatch.observer/filing/0001493152-25-014047.md","text":"https://secwatch.observer/filing/0001493152-25-014047.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1449349/000149315225014047/0001493152-25-014047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1449349/000149315225014047/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:14:06.442359+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}